{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T04:40:20Z","timestamp":1771562420052,"version":"3.50.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,7]],"date-time":"2019-11-07T00:00:00Z","timestamp":1573084800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,11,7]],"date-time":"2019-11-07T00:00:00Z","timestamp":1573084800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["PTDC\/SAU-ONC\/115513\/2009_FCOMP-01-0124-FEDER-015949; PTDC\/SAU-TOX\/114549\/2009"],"award-info":[{"award-number":["PTDC\/SAU-ONC\/115513\/2009_FCOMP-01-0124-FEDER-015949; PTDC\/SAU-TOX\/114549\/2009"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["SFRH\/BPD\/104290\/2014"],"award-info":[{"award-number":["SFRH\/BPD\/104290\/2014"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["SFRH\/BPD\/115730\/2016"],"award-info":[{"award-number":["SFRH\/BPD\/115730\/2016"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["NORTE-01-0145-FEDER-000013 and NORTE-01-0145-FEDER-000023 supported by the Northern Portugal Regional Operational Programme (NORTE 2020), under the Portugal 2020 Partnership Agreement, through the European Regional Development Fund (FEDER); POCI-01-0145-FEDER-007038 FEDER through the Competitiveness Factors Operational Programme (COMPETE)"],"award-info":[{"award-number":["NORTE-01-0145-FEDER-000013 and NORTE-01-0145-FEDER-000023 supported by the Northern Portugal Regional Operational Programme (NORTE 2020), under the Portugal 2020 Partnership Agreement, through the European Regional Development Fund (FEDER); POCI-01-0145-FEDER-007038 FEDER through the Competitiveness Factors Operational Programme (COMPETE)"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["DL 57\/2016\/CP1360\/CT0009"],"award-info":[{"award-number":["DL 57\/2016\/CP1360\/CT0009"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","award":["NIHR Biomedical Research Centre at The Royal Marsden and the ICR"],"award-info":[{"award-number":["NIHR Biomedical Research Centre at The Royal Marsden and the ICR"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011733","name":"Liga Portuguesa Contra o Cancro","doi-asserted-by":"publisher","award":["BOLSA LIGA PORTUGUESA CONTRA CANCRO (LPCC)\/Funda\u00e7\u00e3o PT 2018"],"award-info":[{"award-number":["BOLSA LIGA PORTUGUESA CONTRA CANCRO (LPCC)\/Funda\u00e7\u00e3o PT 2018"]}],"id":[{"id":"10.13039\/501100011733","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Oncol."],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1007\/s13402-019-00475-7","type":"journal-article","created":{"date-parts":[[2019,11,7]],"date-time":"2019-11-07T19:03:05Z","timestamp":1573153385000},"page":"107-121","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Loss of SPINT2 expression frequently occurs in glioma, leading to increased growth and invasion via MMP2"],"prefix":"10.1007","volume":"43","author":[{"given":"M\u00e1rcia Santos","family":"Pereira","sequence":"first","affiliation":[]},{"given":"S\u00f3nia Pires","family":"Celeiro","sequence":"additional","affiliation":[]},{"given":"\u00c2ngela Margarida","family":"Costa","sequence":"additional","affiliation":[]},{"given":"Filipe","family":"Pinto","sequence":"additional","affiliation":[]},{"given":"Sergey","family":"Popov","sequence":"additional","affiliation":[]},{"given":"Gisele Caravina","family":"de Almeida","sequence":"additional","affiliation":[]},{"given":"J\u00falia","family":"Amorim","sequence":"additional","affiliation":[]},{"given":"Manuel Melo","family":"Pires","sequence":"additional","affiliation":[]},{"given":"C\u00e9lia","family":"Pinheiro","sequence":"additional","affiliation":[]},{"given":"Jos\u00e9 Manuel","family":"Lopes","sequence":"additional","affiliation":[]},{"given":"Mrinalini","family":"Honavar","sequence":"additional","affiliation":[]},{"given":"Paulo","family":"Costa","sequence":"additional","affiliation":[]},{"given":"Jos\u00e9","family":"Pimentel","sequence":"additional","affiliation":[]},{"given":"Chris","family":"Jones","sequence":"additional","affiliation":[]},{"given":"Rui Manuel","family":"Reis","sequence":"additional","affiliation":[]},{"given":"Marta","family":"Viana-Pereira","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2019,11,7]]},"reference":[{"key":"475_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21551","volume":"69","author":"RL Siegel","year":"2019","unstructured":"R.L. Siegel, K.D. Miller, A. Jemal, Cancer statistics, 2019. CA Cancer J Clin 69, 7\u201334 (2019)","journal-title":"CA Cancer J Clin"},{"key":"475_CR2","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/sj.bjc.6602321","volume":"92","author":"NG Burnet","year":"2005","unstructured":"N.G. Burnet, S.J. Jefferies, R.J. Benson, D.P. Hunt, F.P. Treasure, Years of life lost (YLL) from cancer is an important measure of population burden--and should be considered when allocating research funds. Br J Cancer 92, 241\u2013245 (2005)","journal-title":"Br J Cancer"},{"issue":"suppl 5","key":"475_CR3","doi-asserted-by":"publisher","first-page":"v1","DOI":"10.1093\/neuonc\/nos218","volume":"14","author":"T. A. Dolecek","year":"2012","unstructured":"T.A. Dolecek, J.M. Propp, N.E. Stroup, C. Kruchko, CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005-2009. Neuro-Oncology 14(Suppl 5), v1\u2013v49 (2012)","journal-title":"Neuro-Oncology"},{"key":"475_CR4","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s00401-007-0243-4","volume":"114","author":"DN Louis","year":"2007","unstructured":"D.N. Louis, H. Ohgaki, O.D. Wiestler, W.K. Cavenee, P.C. Burger, A. Jouvet, B.W. Scheithauer, P. Kleihues, The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114, 97\u2013109 (2007)","journal-title":"Acta Neuropathol"},{"key":"475_CR5","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","volume":"131","author":"DN Louis","year":"2016","unstructured":"D.N. Louis, A. Perry, G. Reifenberger, A. von Deimling, D. Figarella-Branger, W.K. Cavenee, H. Ohgaki, O.D. Wiestler, P. Kleihues, D.W. Ellison, The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathol 131, 803\u2013820 (2016)","journal-title":"Acta Neuropathol"},{"issue":"5","key":"475_CR6","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S1470-2045(09)70025-7","volume":"10","author":"Roger Stupp","year":"2009","unstructured":"R. Stupp, M.E. Hegi, W.P. Mason, M.J. van den Bent, M.J. Taphoorn, R.C. Janzer, S.K. Ludwin, A. Allgeier, B. Fisher, K. Belanger, P. Hau, A.A. Brandes, J. Gijtenbeek, C. Marosi, C.J. Vecht, K. Mokhtari, P. Wesseling, S. Villa, E. Eisenhauer, T. Gorlia, M. Weller, D. Lacombe, J.G. Cairncross, R.O. Mirimanoff, R. European Organisation for, T. Treatment of Cancer Brain, G. Radiation Oncology and G. National Cancer Institute of Canada Clinical Trials, Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncology 10, 459\u2013466 (2009)","journal-title":"The Lancet Oncology"},{"key":"475_CR7","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s00401-007-0293-7","volume":"114","author":"A Claes","year":"2007","unstructured":"A. Claes, A.J. Idema, P. Wesseling, Diffuse glioma growth: a guerilla war. Acta Neuropathol 114, 443\u2013458 (2007)","journal-title":"Acta Neuropathol"},{"key":"475_CR8","first-page":"178","volume":"1825","author":"R Mentlein","year":"2012","unstructured":"R. Mentlein, K. Hattermann, J. Held-Feindt, Lost in disruption: role of proteases in glioma invasion and progression. Biochim Biophys Acta 1825, 178\u2013185 (2012)","journal-title":"Biochim Biophys Acta"},{"key":"475_CR9","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/nrc1121","volume":"3","author":"JS Rao","year":"2003","unstructured":"J.S. Rao, Molecular mechanisms of glioma invasiveness: the role of proteases. Nat Rev Cancer 3, 489\u2013501 (2003)","journal-title":"Nat Rev Cancer"},{"key":"475_CR10","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1023\/A:1014566604005","volume":"56","author":"DK Binder","year":"2002","unstructured":"D.K. Binder, M.S. Berger, Proteases and the biology of glioma invasion. J Neuro-Oncol 56, 149\u2013158 (2002)","journal-title":"J Neuro-Oncol"},{"key":"475_CR11","doi-asserted-by":"publisher","first-page":"12202","DOI":"10.1074\/jbc.272.18.12202","volume":"272","author":"CW Marlor","year":"1997","unstructured":"C.W. Marlor, K.A. Delaria, G. Davis, D.K. Muller, J.M. Greve, P.P. Tamburini, Identification and cloning of human placental bikunin, a novel serine protease inhibitor containing two Kunitz domains. J Biol Chem 272, 12202\u201312208 (1997)","journal-title":"J Biol Chem"},{"key":"475_CR12","doi-asserted-by":"publisher","first-page":"14053","DOI":"10.1074\/jbc.M112263200","volume":"277","author":"K Denda","year":"2002","unstructured":"K. Denda, T. Shimomura, T. Kawaguchi, K. Miyazawa, N. Kitamura, Functional characterization of Kunitz domains in hepatocyte growth factor activator inhibitor type 1. J Biol Chem 277, 14053\u201314059 (2002)","journal-title":"J Biol Chem"},{"key":"475_CR13","doi-asserted-by":"publisher","first-page":"12209","DOI":"10.1074\/jbc.272.18.12209","volume":"272","author":"KA Delaria","year":"1997","unstructured":"K.A. Delaria, D.K. Muller, C.W. Marlor, J.E. Brown, R.C. Das, S.O. Roczniak, P.P. Tamburini, Characterization of placental bikunin, a novel human serine protease inhibitor. J Biol Chem 272, 12209\u201312214 (1997)","journal-title":"J Biol Chem"},{"key":"475_CR14","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1016\/j.febslet.2005.01.085","volume":"579","author":"D Kirchhofer","year":"2005","unstructured":"D. Kirchhofer, M. Peek, M.T. Lipari, K. Billeci, B. Fan, P. Moran, Hepsin activates pro-hepatocyte growth factor and is inhibited by hepatocyte growth factor activator inhibitor-1B (HAI-1B) and HAI-2. FEBS Lett 579, 1945\u20131950 (2005)","journal-title":"FEBS Lett"},{"key":"475_CR15","doi-asserted-by":"publisher","first-page":"29495","DOI":"10.1074\/jbc.M801970200","volume":"283","author":"R Szabo","year":"2008","unstructured":"R. Szabo, J.P. Hobson, K. List, A. Molinolo, C.Y. Lin, T.H. Bugge, Potent inhibition and global co-localization implicate the transmembrane Kunitz-type serine protease inhibitor hepatocyte growth factor activator inhibitor-2 in the regulation of epithelial matriptase activity. J Biol Chem 283, 29495\u201329504 (2008)","journal-title":"J Biol Chem"},{"key":"475_CR16","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1038\/onc.2010.586","volume":"30","author":"R Szabo","year":"2011","unstructured":"R. Szabo, A.L. Rasmussen, A.B. Moyer, P. Kosa, J.M. Schafer, A.A. Molinolo, J.S. Gutkind, T.H. Bugge, c-Met-induced epithelial carcinogenesis is initiated by the serine protease matriptase. Oncogene 30, 2003\u20132016 (2011)","journal-title":"Oncogene"},{"issue":"9","key":"475_CR17","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1038\/jid.2015.160","volume":"135","author":"Soonyean Hwang","year":"2015","unstructured":"S. Hwang, H.E. Kim, M. Min, R. Raghunathan, I.P. Panova, R. Munshi, B. Ryu, Epigenetic silencing of SPINT2 promotes cancer cell motility via HGF-MET pathway activation in melanoma. J Invest Dermatol 135, 2283\u20132291 (2015)","journal-title":"Journal of Investigative Dermatology"},{"issue":"9","key":"475_CR18","doi-asserted-by":"publisher","first-page":"2970","DOI":"10.1111\/cas.13732","volume":"109","author":"Tsuyoshi Fukushima","year":"2018","unstructured":"T. Fukushima, M. Kawaguchi, K. Yamamoto, F. Yamashita, A. Izumi, T. Kaieda, Y. Takezaki, H. Itoh, H. Takeshima, H. Kataoka, Aberrant methylation and silencing of the SPINT2 gene in high-grade gliomas. Cancer Sci 109, 2970\u20132979 (2018)","journal-title":"Cancer Science"},{"issue":"1","key":"475_CR19","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1369\/0022155415612874","volume":"64","author":"M\u00e1rcia Santos Pereira","year":"2015","unstructured":"M.S. Pereira, G.C. de Almeida, F. Pinto, M. Viana-Pereira, R.M. Reis, SPINT2 Deregulation in prostate carcinoma. J Histochem Cytochem 64, 32\u201341 (2016)","journal-title":"Journal of Histochemistry & Cytochemistry"},{"key":"475_CR20","doi-asserted-by":"publisher","first-page":"27558","DOI":"10.1074\/jbc.272.44.27558","volume":"272","author":"T Kawaguchi","year":"1997","unstructured":"T. Kawaguchi, L. Qin, T. Shimomura, J. Kondo, K. Matsumoto, K. Denda, N. Kitamura, Purification and cloning of hepatocyte growth factor activator inhibitor type 2, a Kunitz-type serine protease inhibitor. J Biol Chem 272, 27558\u201327564 (1997)","journal-title":"J Biol Chem"},{"key":"475_CR21","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1023\/A:1015531321445","volume":"19","author":"M Del Rosso","year":"2002","unstructured":"M. Del Rosso, G. Fibbi, M. Pucci, S. D'Alessio, A. Del Rosso, L. Magnelli, V. Chiarugi, Multiple pathways of cell invasion are regulated by multiple families of serine proteases. Clin Exp Metastasis 19, 193\u2013207 (2002)","journal-title":"Clin Exp Metastasis"},{"key":"475_CR22","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1002\/ijc.21881","volume":"119","author":"C Parr","year":"2006","unstructured":"C. Parr, W.G. Jiang, Hepatocyte growth factor activation inhibitors (HAI-1 and HAI-2) regulate HGF-induced invasion of human breast cancer cells. Int J Cancer 119, 1176\u20131183 (2006)","journal-title":"Int J Cancer"},{"key":"475_CR23","doi-asserted-by":"publisher","first-page":"2613","DOI":"10.1002\/ijc.25606","volume":"128","author":"K Nakamura","year":"2011","unstructured":"K. Nakamura, A. Hongo, J. Kodama, Y. Hiramatsu, The role of hepatocyte growth factor activator inhibitor (HAI)-1 and HAI-2 in endometrial cancer. Int J Cancer 128, 2613\u20132624 (2011)","journal-title":"Int J Cancer"},{"key":"475_CR24","doi-asserted-by":"publisher","first-page":"4643","DOI":"10.1038\/onc.2013.412","volume":"33","author":"CH Tsai","year":"2014","unstructured":"C.H. Tsai, C.H. Teng, Y.T. Tu, T.S. Cheng, S.R. Wu, C.J. Ko, H.Y. Shyu, S.W. Lan, H.P. Huang, S.F. Tzeng, M.D. Johnson, C.Y. Lin, P.W. Hsiao, M.S. Lee, HAI-2 suppresses the invasive growth and metastasis of prostate cancer through regulation of matriptase. Oncogene 33, 4643\u20134652 (2014)","journal-title":"Oncogene"},{"key":"475_CR25","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1002\/pros.21177","volume":"70","author":"C Bergum","year":"2010","unstructured":"C. Bergum, K. List, Loss of the matriptase inhibitor HAI-2 during prostate cancer progression. Prostate 70, 1422\u20131428 (2010)","journal-title":"Prostate"},{"key":"475_CR26","doi-asserted-by":"publisher","first-page":"9945","DOI":"10.1158\/0008-5472.CAN-08-2169","volume":"68","author":"PN Kongkham","year":"2008","unstructured":"P.N. Kongkham, P.A. Northcott, Y.S. Ra, Y. Nakahara, T.G. Mainprize, S.E. Croul, C.A. Smith, M.D. Taylor, J.T. Rutka, An epigenetic genome-wide screen identifies SPINT2 as a novel tumor suppressor gene in pediatric medulloblastoma. Cancer Res 68, 9945\u20139953 (2008)","journal-title":"Cancer Res"},{"key":"475_CR27","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1093\/annonc\/mdn556","volume":"20","author":"K Nakamura","year":"2009","unstructured":"K. Nakamura, F. Abarzua, A. Hongo, J. Kodama, Y. Nasu, H. Kumon, Y. Hiramatsu, Hepatocyte growth factor activator inhibitor-2 (HAI-2) is a favorable prognosis marker and inhibits cell growth through the apoptotic pathway in cervical cancer. Ann Oncol 20, 63\u201370 (2009)","journal-title":"Ann Oncol"},{"key":"475_CR28","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1002\/ijc.25161","volume":"127","author":"W Dong","year":"2010","unstructured":"W. Dong, X. Chen, J. Xie, P. Sun, Y. Wu, Epigenetic inactivation and tumor suppressor activity of HAI-2\/SPINT2 in gastric cancer. Int J Cancer 127, 1526\u20131534 (2010)","journal-title":"Int J Cancer"},{"key":"475_CR29","first-page":"8674","volume":"63","author":"K Fukai","year":"2003","unstructured":"K. Fukai, O. Yokosuka, T. Chiba, Y. Hirasawa, M. Tada, F. Imazeki, H. Kataoka, H. Saisho, Hepatocyte growth factor activator inhibitor 2\/placental bikunin (HAI-2\/PB) gene is frequently hypermethylated in human hepatocellular carcinoma. Cancer Res 63, 8674\u20138679 (2003)","journal-title":"Cancer Res"},{"key":"475_CR30","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1023\/A:1025674227750","volume":"64","author":"JM Schuster","year":"2003","unstructured":"J.M. Schuster, M. Longo, P.S. Nelson, Differential expression of bikunin (HAI-2\/PB), a proposed mediator of glioma invasion, by demethylation treatment. J Neuro-Oncol 64, 219\u2013225 (2003)","journal-title":"J Neuro-Oncol"},{"key":"475_CR31","doi-asserted-by":"publisher","first-page":"4598","DOI":"10.1158\/0008-5472.CAN-04-3371","volume":"65","author":"MR Morris","year":"2005","unstructured":"M.R. Morris, D. Gentle, M. Abdulrahman, E.N. Maina, K. Gupta, R.E. Banks, M.S. Wiesener, T. Kishida, M. Yao, B. Teh, F. Latif, E.R. Maher, Tumor suppressor activity and epigenetic inactivation of hepatocyte growth factor activator inhibitor type 2\/SPINT2 in papillary and clear cell renal cell carcinoma. Cancer Res 65, 4598\u20134606 (2005)","journal-title":"Cancer Res"},{"issue":"7","key":"475_CR32","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.jgg.2015.06.003","volume":"42","author":"Eun-Joon Lee","year":"2015","unstructured":"E.J. Lee, P. Rath, J. Liu, D. Ryu, L. Pei, S.K. Noonepalle, A.Y. Shull, Q. Feng, N.S. Litofsky, D.C. Miller, D.C. Anthony, M.D. Kirk, J. Laterra, L. Deng, H.B. Xin, X. Wang, J.H. Choi, H. Shi, Identification ofg global DNA methylation signatures in glioblastoma-derived cancer stem cells. J Genet Genomics 42, 355\u2013371 (2015)","journal-title":"Journal of Genetics and Genomics"},{"key":"475_CR33","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1136\/jclinpath-2011-200358","volume":"65","author":"O Martinho","year":"2012","unstructured":"O. Martinho, C.C. Faloppa, C.S. Neto, A. Longatto-Filho, G. Baiocchi, I.W. da Cunha, F.A. Soares, J.H. Fregnani, R.M. Reis, Loss of RKIP expression during the carcinogenic evolution of endometrial cancer. J Clin Pathol 65, 122\u2013128 (2012)","journal-title":"J Clin Pathol"},{"key":"475_CR34","doi-asserted-by":"publisher","first-page":"690","DOI":"10.3892\/or.2012.2179","volume":"29","author":"O Martinho","year":"2013","unstructured":"O. Martinho, K. Simoes, A. Longatto-Filho, C.E. Jacob, B. Zilberstein, C. Bresciani, J. Gama-Rodrigues, I. Cecconello, V. Alves, R.M. Reis, Absence of RKIP expression is an independent prognostic biomarker for gastric cancer patients. Oncol Rep 29, 690\u2013696 (2013)","journal-title":"Oncol Rep"},{"key":"475_CR35","doi-asserted-by":"publisher","first-page":"e20588","DOI":"10.1371\/journal.pone.0020588","volume":"6","author":"M Viana-Pereira","year":"2011","unstructured":"M. Viana-Pereira, A. Lee, S. Popov, D.A. Bax, S. Al-Sarraj, L.R. Bridges, J.N. Stavale, D. Hargrave, C. Jones, R.M. Reis, Microsatellite instability in pediatric high grade glioma is associated with genomic profile and differential target gene inactivation. PLoS One 6, e20588 (2011)","journal-title":"PLoS One"},{"key":"475_CR36","doi-asserted-by":"publisher","first-page":"e5209","DOI":"10.1371\/journal.pone.0005209","volume":"4","author":"DA Bax","year":"2009","unstructured":"D.A. Bax, S.E. Little, N. Gaspar, L. Perryman, L. Marshall, M. Viana-Pereira, T.A. Jones, R.D. Williams, A. Grigoriadis, G. Vassal, P. Workman, D. Sheer, R.M. Reis, A.D. Pearson, D. Hargrave, C. Jones, Molecular and phenotypic characterisation of paediatric glioma cell lines as models for preclinical drug development. PLoS One 4, e5209 (2009)","journal-title":"PLoS One"},{"issue":"3","key":"475_CR37","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s13402-016-0270-z","volume":"39","author":"Renato Jos\u00e9 Silva-Oliveira","year":"2016","unstructured":"R.J. Silva-Oliveira, V.A. Silva, O. Martinho, A. Cruvinel-Carloni, M.E. Melendez, M.N. Rosa, F.E. de Paula, L. de Souza Viana, A.L. Carvalho, R.M. Reis, Cytotoxicity of allitinib, an irreversible anti-EGFR agent, in a large panel of human cancer-derived cell lines: KRAS mutation status as a predictive biomarker. Cell Oncol 39, 253\u2013263 (2016)","journal-title":"Cellular Oncology"},{"issue":"8","key":"475_CR38","doi-asserted-by":"publisher","first-page":"2471","DOI":"10.1158\/1078-0432.CCR-06-2353","volume":"13","author":"C. Palena","year":"2007","unstructured":"C. Palena, D.E. Polev, K.Y. Tsang, R.I. Fernando, M. Litzinger, L.L. Krukovskaya, A.V. Baranova, A.P. Kozlov, J. Schlom, The human T-box mesodermal transcription factor Brachyury is a candidate target for T-cell-mediated cancer immunotherapy. Clin Cancer Res 13, 2471\u20132478 (2007)","journal-title":"Clinical Cancer Research"},{"key":"475_CR39","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.18632\/oncotarget.2805","volume":"6","author":"AM Costa","year":"2015","unstructured":"A.M. Costa, F. Pinto, O. Martinho, M.J. Oliveira, P. Jordan, R.M. Reis, Silencing of the tumor suppressor gene WNK2 is associated with upregulation of MMP2 and JNK in gliomas. Oncotarget 6, 1422\u20131434 (2015)","journal-title":"Oncotarget"},{"issue":"18","key":"475_CR40","doi-asserted-by":"publisher","first-page":"4949","DOI":"10.1158\/1078-0432.CCR-14-0421","volume":"20","author":"F. Pinto","year":"2014","unstructured":"F. Pinto, N. Pertega-Gomes, M.S. Pereira, J.R. Vizcaino, P. Monteiro, R.M. Henrique, F. Baltazar, R.P. Andrade, R.M. Reis, T-box transcription factor brachyury is associated with prostate cancer progression and aggressiveness. Clin Cancer Res 20, 4949\u20134961 (2014)","journal-title":"Clinical Cancer Research"},{"key":"475_CR41","doi-asserted-by":"publisher","first-page":"e59104","DOI":"10.1371\/journal.pone.0059104","volume":"8","author":"O Martinho","year":"2013","unstructured":"O. Martinho, F. Pinto, S. Granja, V. Miranda-Goncalves, M.A. Moreira, L.F. Ribeiro, C. di Loreto, M.R. Rosner, A. Longatto-Filho, R.M. Reis, RKIP inhibition in cervical cancer is associated with higher tumor aggressive behavior and resistance to cisplatin therapy. PLoS One 8, e59104 (2013)","journal-title":"PLoS One"},{"key":"475_CR42","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1093\/hmg\/dds405","volume":"22","author":"S Moniz","year":"2013","unstructured":"S. Moniz, O. Martinho, F. Pinto, B. Sousa, C. Loureiro, M.J. Oliveira, L.F. Moita, M. Honavar, C. Pinheiro, M. Pires, J.M. Lopes, C. Jones, J.F. Costello, J. Paredes, R.M. Reis, P. Jordan, Loss of WNK2 expression by promoter gene methylation occurs in adult gliomas and triggers Rac1-mediated tumour cell invasiveness. Hum Mol Genet 22, 84\u201395 (2013)","journal-title":"Hum Mol Genet"},{"key":"475_CR43","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1016\/j.biocel.2004.01.013","volume":"36","author":"AC Bellail","year":"2004","unstructured":"A.C. Bellail, S.B. Hunter, D.J. Brat, C. Tan, E.G. Van Meir, Microregional extracellular matrix heterogeneity in brain modulates glioma cell invasion. Int J Biochem Cell Biol 36, 1046\u20131069 (2004)","journal-title":"Int J Biochem Cell Biol"},{"key":"475_CR44","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1002\/(SICI)1097-0215(19990719)82:2<274::AID-IJC19>3.0.CO;2-2","volume":"82","author":"R Hamasuna","year":"1999","unstructured":"R. Hamasuna, H. Kataoka, T. Moriyama, H. Itoh, M. Seiki, M. Koono, Regulation of matrix metalloproteinase-2 (MMP-2) by hepatocyte growth factor\/scatter factor (HGF\/SF) in human glioma cells: HGF\/SF enhances MMP-2 expression and activation accompanying up-regulation of membrane type-1 MMP. Int J Cancer 82, 274\u2013281 (1999)","journal-title":"Int J Cancer"},{"key":"475_CR45","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/S0014-5793(98)01105-3","volume":"436","author":"L Qin","year":"1998","unstructured":"L. Qin, K. Denda, T. Shimomura, T. Kawaguchi, N. Kitamura, Functional characterization of Kunitz domains in hepatocyte growth factor activator inhibitor type 2. FEBS Lett 436, 111\u2013114 (1998)","journal-title":"FEBS Lett"},{"key":"475_CR46","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.jnci.2012.11.001","volume":"25","author":"N Ahmadloo","year":"2013","unstructured":"N. Ahmadloo, A.A. Kani, M. Mohammadianpanah, H. Nasrolahi, S. Omidvari, A. Mosalaei, M. Ansari, Treatment outcome and prognostic factors of adult glioblastoma multiforme. J Egypt Natl Canc Inst 25, 21\u201330 (2013)","journal-title":"J Egypt Natl Canc Inst"},{"key":"475_CR47","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1002\/ijc.1349","volume":"93","author":"R Hamasuna","year":"2001","unstructured":"R. Hamasuna, H. Kataoka, J.Y. Meng, H. Itoh, T. Moriyama, S. Wakisaka, M. Koono, Reduced expression of hepatocyte growth factor activator inhibitor type-2\/placental bikunin (HAI-2\/PB) in human glioblastomas: implication for anti-invasive role of HAI-2\/PB in glioblastoma cells. Int J Cancer 93, 339\u2013345 (2001)","journal-title":"Int J Cancer"},{"key":"475_CR48","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1002\/ijc.24115","volume":"124","author":"EK Tung","year":"2009","unstructured":"E.K. Tung, C.M. Wong, T.O. Yau, J.M. Lee, Y.P. Ching, I.O. Ng, HAI-2 is epigenetically downregulated in human hepatocellular carcinoma, and its Kunitz domain type 1 is critical for anti-invasive functions. Int J Cancer 124, 1811\u20131819 (2009)","journal-title":"Int J Cancer"},{"key":"475_CR49","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1016\/j.ejca.2005.02.014","volume":"41","author":"T Chiba","year":"2005","unstructured":"T. Chiba, O. Yokosuka, K. Fukai, Y. Hirasawa, M. Tada, R. Mikata, F. Imazeki, H. Taniguchi, A. Iwama, M. Miyazaki, T. Ochiai, H. Saisho, Identification and investigation of methylated genes in hepatoma. Eur J Cancer (Oxford, England: 1990) 41, 1185\u20131194 (2005)","journal-title":"Eur J Cancer"},{"key":"475_CR50","first-page":"345","volume":"34","author":"K Nakamura","year":"2009","unstructured":"K. Nakamura, F. Abarzua, J. Kodama, A. Hongo, Y. Nasu, H. Kumon, Y. Hiramatsu, Expression of hepatocyte growth factor activator inhibitors (HAI-1 and HAI-2) in ovarian cancer. Int J Oncol 34, 345\u2013353 (2009)","journal-title":"Int J Oncol"},{"key":"475_CR51","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1002\/ijc.10950","volume":"104","author":"M Suzuki","year":"2003","unstructured":"M. Suzuki, H. Kobayashi, Y. Tanaka, Y. Hirashima, N. Kanayama, Y. Takei, Y. Saga, M. Suzuki, H. Itoh, T. Terao, Suppression of invasion and peritoneal carcinomatosis of ovarian cancer cell line by overexpression of bikunin. Int J Cancer 104, 289\u2013302 (2003)","journal-title":"Int J Cancer"},{"key":"475_CR52","doi-asserted-by":"publisher","first-page":"4034","DOI":"10.1523\/JNEUROSCI.23-10-04034.2003","volume":"23","author":"DM Le","year":"2003","unstructured":"D.M. Le, A. Besson, D.K. Fogg, K.S. Choi, D.M. Waisman, C.G. Goodyer, B. Rewcastle, V.W. Yong, Exploitation of astrocytes by glioma cells to facilitate invasiveness: a mechanism involving matrix metalloproteinase-2 and the urokinase-type plasminogen activator-plasmin cascade. J Neurosci 23, 4034\u20134043 (2003)","journal-title":"J Neurosci"},{"key":"475_CR53","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/s41416-019-0400-2","volume":"120","author":"SR Wu","year":"2019","unstructured":"S.R. Wu, C.H. Lin, H.P. Shih, C.J. Ko, H.Y. Lin, S.W. Lan, H.H. Lin, H.F. Tu, C.C. Ho, H.P. Huang, M.S. Lee, HAI-2 as a novel inhibitor of plasmin represses lung cancer cell invasion and metastasis. Br J Cancer 120, 499\u2013511 (2019)","journal-title":"Br J Cancer"}],"container-title":["Cellular Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13402-019-00475-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13402-019-00475-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13402-019-00475-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,6]],"date-time":"2020-11-06T00:48:48Z","timestamp":1604623728000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13402-019-00475-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,7]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["475"],"URL":"https:\/\/doi.org\/10.1007\/s13402-019-00475-7","relation":{},"ISSN":["2211-3428","2211-3436"],"issn-type":[{"value":"2211-3428","type":"print"},{"value":"2211-3436","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,7]]},"assertion":[{"value":"2 September 2019","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2019","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors disclose no potential conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}}]}}